Van Lanschot Kempen Investment Management N.V. lifted its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 19.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 260,171 shares of the real estate investment trust's stock after acquiring an additional 42,091 shares during the quarter. Van Lanschot Kempen Investment Management N.V. owned 0.11% of Sabra Health Care REIT worth $4,506,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently made changes to their positions in the stock. JPMorgan Chase & Co. boosted its stake in shares of Sabra Health Care REIT by 222.4% in the third quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust's stock valued at $183,996,000 after purchasing an additional 6,819,919 shares during the period. Norges Bank acquired a new position in shares of Sabra Health Care REIT in the fourth quarter worth $48,950,000. Thrivent Financial for Lutherans increased its position in shares of Sabra Health Care REIT by 95.9% during the fourth quarter. Thrivent Financial for Lutherans now owns 1,816,217 shares of the real estate investment trust's stock worth $31,457,000 after acquiring an additional 888,908 shares during the period. Wellington Management Group LLP raised its stake in shares of Sabra Health Care REIT by 33.7% in the fourth quarter. Wellington Management Group LLP now owns 3,205,042 shares of the real estate investment trust's stock valued at $55,511,000 after acquiring an additional 808,207 shares in the last quarter. Finally, Barclays PLC boosted its holdings in Sabra Health Care REIT by 109.4% in the fourth quarter. Barclays PLC now owns 1,420,356 shares of the real estate investment trust's stock valued at $24,601,000 after purchasing an additional 741,959 shares during the period. Hedge funds and other institutional investors own 99.40% of the company's stock.
Sabra Health Care REIT Stock Performance
Shares of SBRA traded down $0.08 during midday trading on Friday, reaching $17.42. 2,009,689 shares of the stock were exchanged, compared to its average volume of 2,138,271. The company has a market capitalization of $4.14 billion, a price-to-earnings ratio of 32.87, a PEG ratio of 1.97 and a beta of 0.93. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. Sabra Health Care REIT, Inc. has a twelve month low of $13.82 and a twelve month high of $20.03. The business's 50-day moving average price is $17.14 and its 200 day moving average price is $17.52.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 EPS for the quarter, hitting the consensus estimate of $0.36. The company had revenue of $182.35 million for the quarter, compared to analyst estimates of $178.01 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. On average, sell-side analysts expect that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.
Sabra Health Care REIT Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.89%. The ex-dividend date was Friday, February 14th. Sabra Health Care REIT's payout ratio is currently 226.42%.
Analyst Ratings Changes
A number of equities research analysts have issued reports on the company. JMP Securities raised Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 price target on the stock in a research report on Tuesday, January 7th. Truist Financial increased their target price on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "hold" rating in a report on Tuesday, March 18th. Finally, Citizens Jmp upgraded Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, January 7th. Three investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, Sabra Health Care REIT has an average rating of "Moderate Buy" and a consensus target price of $19.33.
Read Our Latest Research Report on SBRA
Sabra Health Care REIT Company Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Further Reading
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
